Also mentions Nasdaq:
NASDAQ OMX Reports Record Fourth Quarter 2013 Results
x hide permanently

Tony Gibney Joins InflaRx Board of Directors

GlobeNewswire

JENA, Germany, May 21, 2021 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced Mr. Tony Gibney has been appointed as a Non-Executive Director to the Board of Directors at InflaRx...

Mentions: Nasdaq Germany Board